Sociomarkers to Predict Asthma Control and Emergency Room Visits (SPACER)
Sociomarkers to Predict Asthma Control and Emergency Room Visits (SPACER)
批准号:
10534672
负责人:
Alon Peltz
金额:
$16.93万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-01-15 至 2026-05-31
关键词:
AdultAsthmaAwardChildClassificationClinicalComputer ModelsContinuity of Patient CareDataData SetDemographic FactorsDevelopmentEarly identificationEmergency department visitEnrollmentEnvironmentEnvironmental Risk FactorEvidence based interventionFamilyFinancial HardshipFutureGoalsHealth InsuranceHealth ServicesHealthcareIncentivesIndividualInterventionInvestmentsK-Series Research Career ProgramsLearningLinkLow incomeMachine LearningManaged CareManaged Care ProgramsMeasuresMediatingMedicaidMedicineMentorsMethodsModalityModelingMorbidity - disease rateOutcomePatient Self-ReportPatientsPersonsPharmaceutical PreparationsPhysiciansPopulationPositioning AttributePrivatizationPublic PolicyResearchResearch PersonnelResourcesRiskRisk FactorsSeverity of illnessSocioeconomic FactorsSurveysTimeasthma exacerbationcare seekingclinical riskcostexperiencefood insecurityhealth planhealth recordhigh riskhousing instabilityimprovedmachine learning modelmedical schoolsmedication compliancenetwork modelspredictive modelingpreventprogramsrandom forestrelative costrisk predictionrisk prediction modelscreeningskillssocialsocioeconomic disparity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Asthma impacts more than 25 million adults and children in the U.S. with high associated morbidity and
socioeconomic disparities in outcomes. Because effective medications are available to treat and prevent
exacerbations of asthma and evidence-based interventions exist to mitigate the impact of harmful
socioeconomic factors, early identification of those at highest risk is crucial. However, efforts to predict future
exacerbations of asthma have yielded modest results with infrequent inclusion of comprehensive information
on social hardships, such as food insecurity and housing instability, or financial hardships, such as difficulty
affording the costs of controller medications which is particularly relevant for those with private health
insurance. Identifying social and financial hardships requires broad-based screenings which are resource
intensive, difficult to implement in clinical settings and often incomplete or limited to care seeking populations.
Further, few asthma risk prediction modalities incorporate time-variable (temporal) data on important social,
clinical, and environmental factors. Machine learning, an advanced computational approach to risk prediction,
has great potential to improve upon conventional approaches to risk prediction of asthma exacerbations
through indirect estimation of social hardships and inclusion of temporal risk factors. Implementation of
enhanced asthma risk-prediction models in a health plan setting offers distinct advantages due to existing
investments in asthma care management and access to timely claims data across the full care continuum.
Accordingly, the aims of the SPACER study (Sociomarkers to Predict Asthma Control and Emergency Room
visits) are 1) To describe social and financial hardships in privately insured adults and children with asthma,
and association with medication adherence and exacerbations, 2) To indirectly estimate self-reported social
and financial hardships using routinely collected health plan and spatial data, and 3) To develop and validate a
machine learning network model, incorporating temporal sociomarker, clinical, and environmental data, to
predict asthma exacerbations in a health plan setting. The research leverages the unique research
environment of the Department of Population Medicine, an academic research department of Harvard Medical
School, situated in a regional non-profit health plan, Harvard Pilgrim Health Care. The mentored career
development award will support Dr. Alon Peltz, a physician and health services researcher, in developing
expertise in machine learning modeling and use of social data to improve prediction of adverse clinical
outcomes.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Measuring health disparities using a continuous social risk factor.
使用连续的社会风险因素衡量健康差异。
DOI:
10.1111/1475-6773.14048
发表时间:
2023
期刊:
Health services research
影响因子:
3.4
作者:
[Herrin,Jeph, Barthel,Andrea, Goutos,Demetri, Du,Chengan, Zhou,Sheng, Peltz,Alon, Poyer,James, Lin,Zhenqiu, Bernheim,Susannah]
通讯作者:
Bernheim,Susannah
Annual Variation in 30-Day Risk-Adjusted Readmission Rates in U.S. Children's Hospitals.
美国儿童医院 30 天风险调整再入院率的年度变化。
DOI:
10.1016/j.acap.2022.12.010
发表时间:
2023
期刊:
Academic pediatrics
影响因子:
3.1
作者:
[Bucholz,EmilyM, Hall,Matt, Harris,Mitch, Teufel2nd,RonaldJ, Auger,KatherineA, Morse,Rustin, Neuman,MarkI, Peltz,Alon]
通讯作者:
Peltz,Alon
DOI:
10.1016/j.hpopen.2023.100112
发表时间:
2023-12-15
期刊:
HEALTH POLICY OPEN
影响因子:
--
作者:
[Faugno, Elena, Gilkey, Melissa B., Cripps, Lauren A., Sinaiko, Anna, Peltz, Alon, Kingsdale, Jon, Galbraith, Alison A.]
通讯作者:
Galbraith, Alison A.
DOI:
10.1001/jamahealthforum.2021.4611
发表时间:
2022-01
期刊:
JAMA health forum
影响因子:
--
作者:
[Silvestri D, Goutos D, Lloren A, Zhou S, Zhou G, Farietta T, Charania S, Herrin J, Peltz A, Lin Z, Bernheim S]
通讯作者:
Bernheim S
Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans.
高免赔额健康计划中哮喘儿童和成人的控制药物使用和病情加重。
DOI:
10.1001/jamapediatrics.2021.0747
发表时间:
2021
期刊:
JAMA pediatrics
影响因子:
26.1
作者:
[Galbraith,AlisonA, Ross-Degnan,Dennis, Zhang,Fang, Wu,AnnChen, Sinaiko,Anna, Peltz,Alon, Xu,Xin, Wallace,Jamie, Wharam,JFrank]
通讯作者:
Wharam,JFrank
共 10 条
Sociomarkers to Predict Asthma Control and Emergency Room Visits (SPACER)
-
批准号:10328904
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2021
-
负责人:Alon Peltz
-
依托单位:
海外基金